{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T13:16:31Z","timestamp":1768569391743,"version":"3.49.0"},"posted":{"date-parts":[[2025,6,4]]},"group-title":"Rheumatology","reference-count":29,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,6,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Autoantibodies may play a role in the pathogenesis of myositis and are locally produced within muscle tissue. This study aimed to characterize the local expression of immunoglobulin genes across different subgroups of myositis, identify pathways associated with this expression, and evaluate correlations with disease activity.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Bulk RNA sequencing was performed on muscle biopsies from 289 individuals, including patients with various forms of myositis and healthy controls. Expression levels of immunoglobulin gene regions were compared across clinical and autoantibody-defined subgroups. Pathway enrichment analysis and unsupervised clustering were conducted, and correlations between immunoglobulin gene expression and disease activity were assessed.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Local immunoglobulin gene expression was highest in inclusion body myositis (IBM) and antisynthetase syndrome (ASyS), followed by dermatomyositis, and lowest in immune-mediated necrotizing myopathy. Among isotypes, IgG, IgA, and IgM predominated, while IgD and IgE expression was minimal. Certain immunoglobulin VJ segments were more frequently used across all patients, with no significant differences in specific region usage between patient groups. Immunoglobulin gene expression strongly correlated with disease activity, particularly in patients with anti-Mi2, anti-MDA5, anti-Jo1 autoantibodies, and IBM. Pathway analysis revealed a robust association between immunoglobulin expression and interferon-gamma (IFN-\u03b3) signaling. Unsupervised clustering based solely on immunoglobulin gene expression clearly separated healthy controls from patients with ASyS and IBM.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Immunoglobulin is locally expressed in the muscle of patients with myositis, particularly IBM and ASyS. This expression correlates with disease activity, involves preferential usage of specific isotypes and gene segments, and is closely linked to IFN-\u03b3-associated immune pathways.<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2025.06.03.25328909","type":"posted-content","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T21:30:15Z","timestamp":1749072615000},"source":"Crossref","is-referenced-by-count":0,"title":["Local immunoglobulin expression in myositis is associated with interferon gamma signaling and correlates with disease activity"],"prefix":"10.64898","author":[{"given":"Iago","family":"Pinal-Fernandez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Metz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Casal-Dominguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Pak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raphael","family":"Kirou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Dell\u2019Orso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faiza","family":"Naz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shamima","family":"Islam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo","family":"Gutierrez-Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Werner","family":"Stenzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Selva-O\u2019Callaghan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose C.","family":"Milisenda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew L.","family":"Mammen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2025060606301394000_2025.06.03.25328909v1.1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30254-0"},{"issue":"11","key":"2025060606301394000_2025.06.03.25328909v1.2","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1136\/ard-2024-225773","article-title":"Pathological autoantibody internalisation in myositis","volume":"83","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"2025060606301394000_2025.06.03.25328909v1.3","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000187124.92826.20"},{"key":"2025060606301394000_2025.06.03.25328909v1.4","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-eular.2177"},{"key":"2025060606301394000_2025.06.03.25328909v1.5","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.59.8.1170"},{"key":"2025060606301394000_2025.06.03.25328909v1.6","doi-asserted-by":"publisher","DOI":"10.1002\/mus.21739"},{"key":"2025060606301394000_2025.06.03.25328909v1.7","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000451"},{"issue":"23","key":"2025060606301394000_2025.06.03.25328909v1.8","first-page":"e2068","article-title":"Muscular and extramuscular clinical features of patients with anti-PM\/Scl autoantibodies","volume":"90","year":"2018","journal-title":"Neurology"},{"issue":"2","key":"2025060606301394000_2025.06.03.25328909v1.9","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00401-022-02438-z","article-title":"Skeletal muscle provides the immunological micro-milieu for specific plasma cells in anti-synthetase syndrome-associated myositis","volume":"144","year":"2022","journal-title":"Acta Neuropathol"},{"key":"2025060606301394000_2025.06.03.25328909v1.10","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000642"},{"issue":"3","key":"2025060606301394000_2025.06.03.25328909v1.11","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/art.41964","article-title":"Performance of the 2017 European Alliance of Associations for Rheumatology\/American College of Rheumatology Classification Criteria for Idiopathic Inflammatory Myopathies in Patients With Myositis-Specific Autoantibodies","volume":"74","year":"2022","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"2025060606301394000_2025.06.03.25328909v1.12","first-page":"e1193","article-title":"Identification of distinctive interferon gene signatures in different types of myositis","volume":"93","year":"2019","journal-title":"Neurology"},{"issue":"8","key":"2025060606301394000_2025.06.03.25328909v1.13","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/art.40883","article-title":"Myositis Autoantigen Expression Correlates With Muscle Regeneration but Not Autoantibody Specificity","volume":"71","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"2025060606301394000_2025.06.03.25328909v1.14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40478-017-0427-7","article-title":"Calcium dysregulation, functional calpainopathy, and endoplasmic reticulum stress in sporadic inclusion body myositis","volume":"5","year":"2017","journal-title":"Acta Neuropathol Commun"},{"key":"2025060606301394000_2025.06.03.25328909v1.15","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-021-02365-5"},{"key":"2025060606301394000_2025.06.03.25328909v1.16","doi-asserted-by":"crossref","unstructured":"Pinal-Fernandez I , Milisenda JC , Pak K , Munoz-Braceras S , Casal-Dominguez M , Torres-Ruiz J , et al. Transcriptional derepression of CHD4\/NuRD-regulated genes in the muscle of patients with dermatomyositis and anti-Mi2 autoantibodies. Ann Rheum Dis. 2023.","DOI":"10.1136\/ard-2023-223873"},{"key":"2025060606301394000_2025.06.03.25328909v1.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2023.08.015"},{"key":"2025060606301394000_2025.06.03.25328909v1.18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1177721"},{"key":"2025060606301394000_2025.06.03.25328909v1.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.04.004"},{"key":"2025060606301394000_2025.06.03.25328909v1.20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2117912"},{"key":"2025060606301394000_2025.06.03.25328909v1.21","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.48.3.712"},{"key":"2025060606301394000_2025.06.03.25328909v1.22","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-4422(21)00159-9"},{"key":"2025060606301394000_2025.06.03.25328909v1.23","doi-asserted-by":"crossref","first-page":"1447182","DOI":"10.3389\/fimmu.2024.1447182","article-title":"Treatment of refractory immune-mediated necrotizing myopathy with efgartigimod","volume":"15","year":"2024","journal-title":"Front Immunol"},{"issue":"1","key":"2025060606301394000_2025.06.03.25328909v1.24","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s12883-024-03804-y","article-title":"Efgartigimod combined with steroids as a fast-acting therapy for myasthenic crisis: a case report","volume":"24","year":"2024","journal-title":"BMC Neurol"},{"key":"2025060606301394000_2025.06.03.25328909v1.25","doi-asserted-by":"publisher","DOI":"10.1002\/art.37754"},{"issue":"2","key":"2025060606301394000_2025.06.03.25328909v1.26","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/acr.22920","article-title":"Longitudinal Course of Disease in a Large Cohort of Myositis Patients With Autoantibodies Recognizing the Signal Recognition Particle","volume":"69","year":"2017","journal-title":"Arthritis Care Res (Hoboken"},{"issue":"3","key":"2025060606301394000_2025.06.03.25328909v1.27","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/art.38270","article-title":"Predictors of clinical improvement in rituximab-treated refractory adult and juvenile dermatomyositis and adult polymyositis","volume":"66","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2025060606301394000_2025.06.03.25328909v1.28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2308917"},{"key":"2025060606301394000_2025.06.03.25328909v1.29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2408786"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2025.06.03.25328909","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T20:37:37Z","timestamp":1768509457000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2025.06.03.25328909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":29,"URL":"https:\/\/doi.org\/10.1101\/2025.06.03.25328909","relation":{},"subject":[],"published":{"date-parts":[[2025,6,4]]},"subtype":"preprint"}}